IDO1 and cancer: Except IDO and TDO various enzymes of the kynurenine pathway have been identified as potential targets in cancer treatment such as nicotinamide phosphoribosyltransferase (NMPRT), nicotinamide N-methyltransferase (NNMT) and poly-(ADP-ribose) polymerase (PARP) [132].